|
|
| Research article summary (published 14 Sep 2009): |
Antidepressant actions of histone deacetylase inhibitors.
Full Abstract
Persistent symptoms of depression suggest the involvement of stable molecular adaptations in brain, which may be reflected at the level of chromatin remodeling. We find that chronic social defeat stress in mice causes a transient decrease, followed by a persistent increase, in levels of acetylated histone H3 in the nucleus accumbens, an important limbic brain region. This persistent increase in H3 acetylation is associated with decreased levels of histone deacetylase 2 (HDAC2) in the nucleus accumbens. Similar effects were observed in the nucleus accumbens of depressed humans studied postmortem. These changes in H3 acetylation and HDAC2 expression mediate long-lasting positive neuronal adaptations, since infusion of HDAC inhibitors into the nucleus accumbens, which increases histone acetylation, exerts robust antidepressant-like effects in the social defeat paradigm and other behavioral assays. HDAC inhibitor [N-(2-aminophenyl)-4-[N-(pyridine-3-ylmethoxy-carbonyl)aminomethyl]benzamide (MS-275)] infusion also reverses the effects of chronic defeat stress on global patterns of gene expression in the nucleus accumbens, as determined by microarray analysis, with striking similarities to the effects of the standard antidepressant fluoxetine. Stress-regulated genes whose expression is normalized selectively by MS-275 may provide promising targets for the future development of novel antidepressant treatments. Together, these findings provide new insight into the underlying molecular mechanisms of depression and antidepressant action, and support the antidepressant potential of HDAC inhibitors and perhaps other agents that act at the level of chromatin structure.
Author information
Author/s: Covington, Herbert E (HE); Maze, Ian (I); LaPlant, Quincey C (QC); Vialou, Vincent F (VF); Ohnishi, Yoshinori N (YN); Berton, Olivier (O); Fass, Dan M (DM); Renthal, William (W); Rush, Augustus J (AJ); Wu, Emma Y (EY); Ghose, Subroto (S); Krishnan, Vaishnav (V); Russo, Scott J (SJ); Tamminga, Carol (C); Haggarty, Stephen J (SJ); Nestler, Eric J (EJ);
Affiliation: Fishberg Department of Neuroscience, Mount Sinai School of Medicine, New York, New York 10029, USA.
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci), published in United States. (Language: eng)
Reference: 2009-Sep; vol 29 (issue 37) : pp 11451-60
Dates: Created 2009/09/17; Completed 2009/10/02; Revised 2009/11/12;
PMID: 19759294, status: MEDLINE (last retrieval date: 11/15/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- HDAC2 deficiency and histone acetylation.
29 Jun 2008 - Histone deacetylase activity and COPD.
2 Aug 2005 - HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
29 Nov 2008 - Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
10 Sep 2008 - Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
2 Sep 2007 - Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.
30 Dec 2001 - A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
29 Mar 1998 - Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts.
11 Apr 2001 - Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
25 Apr 2006 - MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.
30 Oct 2002
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.